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Abstract
The objective of the present study was to translate the Kidney Disease
Quality of Life - Short Form (KDQOL-SF™ 1.3) questionnaire into
Portuguese to adapt it culturally and validate it for the Brazilian
population. The KDQOL-SF was translated into Portuguese and back-
translated twice into English. Patient difficulties in understanding the
questionnaire were evaluated by a panel of experts and solved. Meas-
urement properties such as reliability and validity were determined by
applying the questionnaire to 94 end-stage renal disease patients on
chronic dialysis. The Nottingham Health Profile Questionnaire, the
Karnofsky Performance Scale and the Kidney Disease Questionnaire
were administered to test validity. Some activities included in the
original instrument were considered to be incompatible with the
activities usually performed by the Brazilian population and were
replaced. The mean scores for the 19 components of the KDQOL-SF
questionnaire in Portuguese ranged from 22 to 91. The components
“Social support” and “Dialysis staff encouragement” had the highest
scores (86.7 and 90.8, respectively). The test-retest reliability and the
inter-observer reliability of the instrument were evaluated by the
intraclass correlation coefficient. The coefficients for both reliability
tests were statistically significant for all scales of the KDQOL-SF (P <
0.001), ranging from 0.492 to 0.936 for test-retest reliability and from
0.337 to 0.994 for inter-observer reliability. The Cronbach’s α coeffi-
cient was higher than 0.80 for most of components. The Portuguese
version of the KDQOL-SF questionnaire proved to be valid and
reliable for the evaluation of quality of life of Brazilian patients with
end-stage renal disease on chronic dialysis.
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Introduction
Despite the enormous advances in dialy-
sis therapy for increasing the life expectancy
of patients with end-stage renal disease
(ESRD), the negative impact of the disease
and its treatment affect the perception of
patients regarding their health-related qual-
ity of life (HRQOL) (1), a factor that can
interfere with treatment outcome.
Many efforts have been made to reduce
this problem and to increase the quality of
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life of those who depend on dialysis. Among
these, particularly important is the role of
assessment of HRQOL by the application of
generic and specific measures that are used
to examine which dimensions or areas of life
of the patients are impaired and need to
receive an appropriate intervention.
Generic questionnaires are used in gen-
eral populations to assess different types of
disease, permitting research about health sta-
tus and comparison of the data obtained with
those for the general population. Specific
questionnaires assess a particular disease,
population or specific problem. They are
useful to determine the specific effects of a
disease on daily patient life and to obtain
separate scores for each dimension assessed
(2,3).
The increasing use of these instruments
in multinational studies has resulted in the
translation of an original questionnaire into
different languages, and publications about
the translation process have led to equiva-
lence between the original version and the
translated versions (4,5). Moreover, guide-
lines have been provided to allow appropri-
ate testing of the properties, reliability and
validity of the instrument on target popula-
tions (6).
Our choice of the Kidney Disease and
Quality of Life - Short Form (KDQOL-SF™)
(7) was based on the need to obtain a specific
instrument to evaluate patients on dialysis
with kidney disease, since a specific instru-
ment applicable to all types of dialysis treat-
ments has not been available in Brazil. The
KDQOL-SF is derived from the KDQOL
(8), the long-form of the questionnaire, whose
use is limited by its length (134 items). The
KDQOL-SF was developed in the US by
Ron Hays and was translated into Spanish,
Italian, German, Japanese, French, Chinese,
and Dutch. It is a self-administered instru-
ment that includes the MOS 36 Item Short-
Form Health Survey (SF-36) (9) as a generic
measure and the questions targeted at par-
ticular health-related concerns for patients
on dialysis. The questionnaire has been used
in the United States Renal Data System -
Annual Data Report (10) and is one of the
most complete instruments currently avail-
able to assess the HRQOL of patients be-
cause it includes general and specific as-
pects of health, allowing a more complete
evaluation of HRQOL dimensions that are
relevant for the patients (11). Furthermore, it
has been tested on different populations with
ESRD (12,13).
The aim of the present study was to trans-
late the KDQOL-SF into Portuguese, to adapt
it culturally to Brazil, and to determine the
psychometric properties, reliability and va-
lidity of dimensions for the assessment of
HRQOL of patients on dialysis therapy in
Brazil.
 Subjects and Methods
The study protocol was approved by the
Ethics Committees of Universidade Federal
de São Paulo, Escola Paulista de Medicina,
and of Faculdade de Medicina de São José
do Rio Preto, São José do Rio Preto, SP,
Brazil. The sample was obtained at the Fa-
culdade de Medicina de São José do Rio
Preto.
Structure of the KDQOL-SF
The KDQOL-SF is a self-reported meas-
ure that assesses the functioning and well-
being of people with kidney disease and on
dialysis (8). The questionnaire consists of 80
items divided into 19 dimensions: SF-36 (8
dimensions/36 items): physical functioning
(10 items), role limitations caused by physi-
cal problems (4 items), role limitations caused
by emotional problems (3 items), pain (2
items), general health perceptions (5 items),
social functioning (2 items), emotional well-
being (5 items), energy/fatigue (4 items),
and 1 item about health status compared to
one year ago; kidney-disease-targeted items
(11 dimensions/43 items): symptom/prob-
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lem list (12 items), effects of kidney disease
(8 items), burden of kidney disease (4 items),
cognitive function (3 items), quality of so-
cial interaction (3 items), sexual function (2
items), sleep (4 items), social support (2
items), work status (2 items), overall health
rating (1 item scored separately), patient sat-
isfaction (1 item), and dialysis staff encour-
agement (2 items). The scores on each di-
mension range from 0 to 100, with higher
scores reflecting better HRQOL. The change
in health (question 2) of SF-36 and the 0-10
overall health rating items (question 22) are
scored as single items (7).
Cultural adaptation
Permission to translate the KDQOL-SF
into Portuguese was obtained from the prin-
cipal author, Ron D. Hays, who authorized
its use in Brazil. The first translation step
was carried out according to specifications
established by the KDQOL Working Group
(14) and consisted of preparing a translated
version of the questionnaire which was lin-
guistically and conceptually equivalent to
the original English version. Two transla-
tions into the Portuguese language were done
(one by the investigators and another by a
certified translator). Both versions were re-
vised by a specialized translator who evalu-
ated the level of difficulty for translation
using a scale from 0 (“not at all difficult”) to
100 (“most difficult”) and the equivalence
of each item and response scale according to
a scale from 0 (“not at all equivalent”) to 100
(“exactly equivalent”). The translators com-
pared their translations, reconciled discrep-
ancies and established a Portuguese version
to be applied to patients with ESRD. Thirty
patients undergoing dialysis in the city of
São José do Rio Preto were randomly se-
lected for this phase of the study.
The feasibility of the instrument and the
difficulties found by the patients were evalu-
ated by a panel including experts in kidney
disease and two patients of different educa-
tional levels. Changes were made based on
the difficulties of the patients to understand,
and a dictionary of synonyms was used to
establish a simpler vocabulary for the over-
all population.
Subsequently, two back-translations were
done by US native translators and compared
to the original English version. The discrep-
ancies between the back-translations were
resolved. A memo summarizing these steps
was submitted to the KDQOL Working
Group that authorized the investigators to
proceed with the validation of the question-
naire.
Reliability
Reliability or reproducibility is defined
as the capacity of an instrument to yield
similar results after repeated application to
stable patients (15). Inter-observer reliabil-
ity is the degree of agreement of results
obtained by different observers, and intra-
observer reliability is the degree of agree-
ment of results obtained by the same observ-
ers at different times (16).
The reliability of the Portuguese version
of the KDQOL-SF was tested in two inter-
views. Ninety-four patients with ESRD were
randomly selected from dialysis unit in the
city of São José do Rio Preto, in the interior
of São Paulo State, and evaluated by two
interviewers at different times. Two assess-
ments were made independently by observ-
ers No. 1 and No. 2 on the same day (inter-
observer reliability). Seven days after the
first assessment, another interview (N = 93)
was done by interviewer No. 1 (intra-ob-
server reliability). One patient included in
the study died during the time between the
first and second interview.
Validity
Validity analyzes if the instrument meas-
ures what it purports to measure (15). To
evaluate the validity a sample of 74 patients
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was selected at random. Sociodemographic,
clinical and laboratory parameters were col-
lected during the initial patient interview and
after revision of the data available in the
medical records. The clinical parameters in-
vestigated were type of dialysis treatment
and co-morbidities (cardiovascular diseases,
chronic obstructive lung disease, peripheral
vascular disease, diabetes mellitus, cere-
brovascular disease, liver disease, hyperten-
sion, visual deficit, ambulation deficit, and
cancer). The laboratory parameters analyzed
were hematocrit and Kt/V.
To evaluate the construct validity, the
KDQOL-SF was compared with the follow-
ing questionnaires already translated into
Portuguese, the Nottingham Health Profile
(NHP) and the Karnofsky Performance Scale
(KPS) and validated in Brazil, the Kidney
Disease Questionnaire (KDQ).
The NHP (17) is an instrument for global
assessment that contains 38 items divided
into 6 dimensions: level of energy, pain,
emotional reactions, sleep, social isolation,
and physical capacity. The scores range from
0 to 100 (0 = better health status, 100 =
worse health status). The NHP has been used
in studies on renal patients (12).
The KPS (18) is a clinician-assessed scale
consisting of 11 categories that range from
normal functioning (100) to death (0). Scores
ranging from 80 to 100 indicate capacity to
exert normal activities and to work, scores
from 50 to 70 indicate that the patients are
able to take care of themselves but not to
work, and scores <50 indicate that the pa-
tients need continued assistance and medical
care. The application of the KPS to renal
patients has been reported in some studies
(19).
The KDQ (20) is a specific questionnaire
for chronic kidney disease and contains 26
questions divided into 5 dimensions: physi-
cal symptoms, fatigue, depression, relation-
ships with others, and frustration. The items
are scored on a 7-point Likert scale (1 = a
serious problem, 7 = no problem), with high
scores indicating a better health status. The
KDQ was translated and validated in Brazil
by Sesso and Yoshihiro (21,22).
Statistical analysis
Descriptive statistical analysis was used
for the sociodemographic, clinical and labo-
ratory data of patients assessed in the various
stages of this study.
The intra-class correlation coefficient and
the Cronbach’s α coefficient (23) were used
to assess intra-observer (test-retest) and in-
ter-observer agreement. The values for the
interpretation of the intraclass correlation
coefficient were: <0.4, weak agreement; 0.4
to 0.75, good agreement; ≥0.75, excellent
agreement. The α value used as a criterion of
adequate internal consistency reliability was
0.70 or higher (24).
The validity of the KDQOL-SF was as-
sessed using Pearson’s correlation coeffi-
cient between the sociodemographic, clini-
cal and laboratory results obtained with it
and those obtained with the questionnaires
NHP, KPS and KDQ.
The Statistical Package for the Social
Sciences (SPSS), version 10.0 for Windows
was used for the analyses. The tests were
two-tailed and P < 0.05 was considered to
indicate statistical significance.
Results
We did not observe translation difficul-
ties and found equivalence between the ori-
ginal version and the Portuguese version of
the KDQOL. However, some activities in
the original version had to be replaced:
“vacuum” was replaced with “sweep the
floor”, and “play golf” was replaced with
“walking for over an hour” (the latter modi-
fication was also made in the Spanish ver-
sion) since these are not regular activities for
the Brazilian population. For a few items, it
was suggested to include an explanation in
parentheses to facilitate the understanding
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of patients of lower educational level. We
conclude that the guidelines established by
the authors’ group facilitated this stage and
that the participation of patients in the panel
group was fundamental for a better cultural
adaptation of the original KDQOL-SF to our
setting.
Of the 94 patients who participated in the
validation process, 55% were males, mean
patient age was 49 ± 13 years (23-82 years),
most were Caucasians (74%), had incom-
plete elementary school (1st to 8th grade;
56%), and lived in towns surrounding São
José do Rio Preto (55%). Forty-six percent
of the patients were retired.
The most common primary causes of
renal failure were glomerulonephritis (31%),
hypertension (25%), and diabetes (8%). The
co-morbid conditions most frequently found
were hypertension (66%), difficulty to walk
(14%), and liver disease (7%). Fifty-seven
percent of the patients were receiving hemo-
dialysis and 43% were on peritoneal dialy-
sis. The mean number of hours of treatment
for patients on hemodialysis was 12 h/week,
and 50% had an arteriovenous fistula as
vascular access for dialysis. The median time
of ESRD among the patients was 2 years and
14% had previously received a kidney trans-
plant that had functioned during a median
time of 63 ± 43 months (9-132 months).
The mean hematocrit was 34 ± 5% (16-
47%) and mean Kt/V (for patients on hemodi-
alysis) in the last two months was 1.33 ± 0.36.
When the Portuguese version of KDQOL-
SF was applied the mean values obtained for
each dimension of the questionnaire ranged
from 22 to 91; the dimensions “Social sup-
port” and “Dialysis staff encouragement”
had the highest values, and the dimensions
“Work status”, “Sexual function” and “Bur-
den of kidney disease” had the lowest values
(Table 1).
Reliability
The reliability of intra- and inter-observer
evaluations was statistically significant for
all 19 scales of the KDQOL-SF. High values
for the Cronbach’s α coefficient were ob-
tained for most of the dimensions evaluated.
Intra-observer reliability assessed by the
Cronbach’s α coefficient ranged from 0.65
(Patient satisfaction) to 0.96 (Work status),
and inter-observer reliability ranged from
0.71 (Cognitive function) to 0.99 (Sexual
function), with the exception of the dimen-
sion “Patient satisfaction” (r = 0.50), which
had a lower value, although statistically sig-
nificant, when evaluated by the intra-class
correlation coefficient. These results are pre-
sented in Table 2.
Validity
Table 3 shows the correlation coefficients
between the dimensions of the KDQOL-SF
and the sociodemographic, clinical and labo-
ratory parameters. Educational level and
number of co-morbidities showed the most
Table 1. Scores obtained for the Brazilian Portuguese version of the Kidney Disease
and Quality of Life - Short Form questionnaire applied to end-stage renal disease
patients.
Dimension   Mean ± SD Minimum-Maximum
General health 59 ± 27 0-100
Physical functioning 61 ± 27 0-100
Physical role 59 ± 38 0-100
Emotional role 71.28 ± 38.37 0-100
Pain 67.45 ± 26.45 0-100
Social function 76.65 ± 26.89 0-100
Emotional well-being 66.18 ± 24.88 4-100
Energy/fatigue 60.64 ± 25.57 0-100
Burden of kidney disease 46.68 ± 31.24 0-100
Cognitive function 78.44 ± 24.23 0-100
Quality of social interaction 80.92 ± 20.45 20-100
Symptom/problem list 81.25 ± 15.66 29-100
Effects of kidney disease 73.37 ± 16.21 25-100
Sexual function 35.64 ± 43.53 0-100
Sleep 75.56 ± 21.01 5-100
Social support 86.70 ± 22.87 0-100
Work status 22.34 ± 35.63 0-100
Patient satisfaction 72.69 ± 18.59 33-100
Dialysis staff encouragement 90.82 ± 17.98 0-100
Values for all dimensions vary from 0 to 100 (best quality of life). The questionnaire
was completed by 53 hemodialysis patients and by 41 peritoneal dialysis patients.
The data were obtained in the first application of the questionnaire.
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significant correlations with most of the
KDQOL-SF dimensions. Time of treatment
did not correlate significantly with the di-
mensions.
Table 4 presents the correlation coeffi-
cients between the dimensions of the
KDQOL-SF and the dimensions of the NHP.
The best correlations were observed between
Physical functioning (KDQOL-SF) and
Physical capacity (NHP), and between the
two dimensions of KDQOL-SF, Emotional
well-being and Quality of social interaction
with the dimension of NHP, Emotional reac-
tions. Some dimensions of the KDQOL-SF
presented statistically significant correlations
with only one of the NHP dimensions: Sexual
function (KDQOL-SF) and Physical capac-
ity (NHP), Social support and Social isola-
tion, and Dialysis staff encouragement and
Pain, respectively.
The correlation coefficients between the
dimensions of the KDQOL-SF and most di-
mensions of the KPS were statistically sig-
nificant, except for Cognitive function, Sleep,
Social support, Patient satisfaction, and Di-
alysis staff encouragement (Table 5).
In the comparison with the KDQ dimen-
sions, correlation coefficients were statisti-
cally significant for the following KDQOL-
SF dimensions: Physical functioning, Physi-
cal role, Emotional role, Pain, Social func-
tion, Emotional well-being, Energy/fatigue,
Burden of kidney disease, Cognitive func-
tion, Quality of social interaction, Symptom/
problems, Effects of kidney disease, Sleep.
The best correlation coefficients were ob-
tained between Emotional well-being
(KDQOL-SF) and Depression (KDQ) and
between Energy/fatigue and Fatigue (KDQ),
respectively. Sexual function, Patient satis-
faction and Dialysis staff encouragement did
not correlate with the components of the
KDQ (Table 6).
Discussion
The methods used to translate and validate
Table 3. Pearson’s correlation coefficients between the mean value of each dimension of the
Brazilian Portuguese version of the Kidney Disease and Quality of Life - Short Form and
the sociodemographic, clinical and laboratory parameters of the patients (N = 94).
Dimensions of the Age Educational Time of Number of Hema-
KDQOL-SF level treatment co-morbidities tocrit
General health -0.173 0.149 0.021 -0.144 -0.031
Physical functioning -0.505* 0.286* -0.036 -0.376* -0.204*
Physical role -0.239* 0.167 0.063 -0.305* 0.146
Emotional role -0.136 0.196 0.197 -0.253* -0.016
Pain -0.140 0.171 0.086 -0.329* -0.103
Social function -0.183 0.267* 0.064 -0.365* -0.076
Emotional well-being -0.161 0.294* 0.101 -0.315* 0.012
Energy/fatigue -0.270* 0.293* -0.067 0.218* -0.170
Burden of kidney disease -0.180 0.288* 0.182 -0.146 -0.030
Cognitive function -0.181 0.265* -0.194 -0.152 0.088
Quality of social interaction -0.070 0.186 0.164 -0.143 -0.003
Symptom/problem list -0.302* 0.248* 0.095 -0.289* -0.039
Effects of kidney disease -0.032 0.323* 0.140 -0.176 0.042
Sexual function -0.303* 0.046 -0.070 -0.191 -0.256*
Sleep -0.110 0.030 0.107 -0.009 0.204*
Social support 0.103 0.034 -0.019 -0.014 0.004
Work status -0.052 0.127 -0.008 -0.131 -0.056
Patient satisfaction 0.037 0.139 0.030 0.069 0.100
Dialysis staff encouragement -0.017 0.053 0.111 0.145 0.221*
*P < 0.05 for the correlation.
Table 2. Intra- and inter-observer reliability of each dimension of the Brazilian Portu-
guese version of the Kidney Disease and Quality of Life - Short Form evaluated by the
intraclass correlation coefficient (ICC) and the Cronbach’s α coefficient (Cα).
Dimensions of the ICC (intra-observer) Cα ICC (inter-observer) Cα
KDQOL-SF
General health 0.7174* 0.8354 0.8633* 0.9265
Physical functioning 0.8952* 0.9433 0.9614* 0.9795
Physical role 0.6407* 0.7786 0.8139* 0.8941
Emotional role 0.6164* 0.7618 0.6853* 0.8125
Pain 0.6658* 0.7989 0.7995* 0.8881
Social function 0.5982* 0.7459 0.5805* 0.7329
Emotional well-being 0.7647* 0.8666 0.7121* 0.8297
Energy/fatigue 0.7141* 0.8313 0.7938* 0.8848
Burden of kidney disease 0.8651* 0.9277 0.9191* 0.9561
Cognitive function 0.6370* 0.7729 0.5532* 0.7115
Quality of social interaction 0.6944* 0.8170 0.7678* 0.8686
Symptom/problem list 0.8495* 0.9158 0.8999* 0.9436
Effects of kidney disease 0.7672* 0.8683 0.7058* 0.8261
Sexual function 0.8148* 0.8979 0.9940* 0.9970
Sleep 0.7355* 0.8473 0.8586* 0.9238
Social support 0.6246* 0.7689 0.8792* 0.9140
Work status 0.9363* 0.9671 0.9664* 0.9829
Patient satisfaction 0.4916* 0.6584 0.3365* 0.5035
Dialysis staff encouragement 0.7442* 0.8484 0.9230* 0.9591
The intra-observer test was carried out with 93 patients and inter-observer test with
39 patients. The test-retest interval was 7 days. ICC of 0.4 = weak agreement; 0.4 to
0.75 = good agreement; ≥0.75 = excellent agreement. Cα ranges from 0 to 1 with
values above 0.70 considered as satisfactory (or good/excellent) reliability (Ref. 24).
*P < 0.001 comparing the two evaluations of each dimension (ICC or Cα).
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the quality of life questionnaires used in Ne-
phrology are often inadequate. Additional prob-
lems are the wrong choice of questionnaire or
problems with its utilization. The KDQOL-SF
has many advantages compared to other in-
struments because it has been tested in several
populations with kidney disease, it has both
general and specific modules to assess chronic
kidney disease, it can be used both for patients
on hemodialysis and peritoneal dialysis, it has
questions about the sexual area and profes-
sional rehabilitation, and can be self-applied
or applied by an interviewer (7).
The SF-36 had already been translated
into Portuguese by Ciconelli et al. (25), and
was translated again in the present study, as
part of the translation of the KDQOL-SF
questionnaire as a whole. Some items and
activities were modified, but the patients did
not have difficulties in understanding the
activity “bowling”, in contrast to patients
with rheumatoid arthritis. Nevertheless, we
Table 4. Pearson’s correlation coefficient between the mean values of the dimensions of the Brazilian
Portuguese version of the Kidney Disease and Quality of Life - Short Form and the mean values of the
dimensions of the Nottingham Health Profile (N = 74).
Dimensions of the KDQOL-SF Level of Pain Emotional Sleep Social Physical
 energy reactions isolation capacity
General health -0.259* -0.429* -0.317* -0.183 -0.249* -0.205
Physical functioning -0.611* -0.484* -0.465* -0.347* -0.370* -0.715*
Physical role -0.440* -0.317* -0.442* -0.341* -0.320* -0.412*
Emotional role -0.424* -0.274* -0.589* -0.441* -0.356* -0.329*
Pain -0.304* -0.566* -0.376* -0.255* -0.376* -0.334*
Social function -0.528* -0.262* -0.614* -0.309* -0.538* -0.558*
Emotional well-being -0.506* -0.381* -0.778* -0.444* -0.601* -0.304*
Energy/fatigue -0.633* -0.480* -0.594* -0.422* -0.460* -0.471*
Burden of kidney disease -0.426* -0.409* -0.554* -0.446* -0.488* -0.371*
Cognitive function -0.423* -0.346* -0.633* -0.339* -0.575* -0.389*
Quality of social interaction -0.401* -0.466* -0.729* -0.387* -0.639* -0.385*
Symptom/problem list -0.562* -0.581* -0.475* -0.410* -0.437* -0.457*
Effects of kidney disease -0.260* -0.271* -0.255* -0.231* -0.232* -0.224
Sexual function -0.214 0.070 -0.094 -0.001 -0.221 -0.240*
Sleep -0.376* -0.255* -0.546* -0.690* -0.420* -0.279*
Social support -0.082 0.083 -0.222 0.076 -0.373* 0.027
Work status -0.344* -0.154 -0.301* -0.425* -0.166 -0.203
Patient satisfaction -0.151 -0.030 -0.080 -0.064 0.064 0.017
Dialysis staff encouragement -0.178 -0.262* -0.186 -0.084 -0.130 -0.058
The questionnaire Nottingham Health Profile is described in Ref. 17.
*P < 0.05 for the correlation.
Table 5. Pearson’s correlation coefficient between
the mean values of the dimensions of the Brazil-
ian Portuguese version of the Kidney Disease and
Quality of Life - Short Form and the mean values
of the dimensions of the Karnofsky Performance
Scale (KPS, N = 74).
Dimensions of the KDQOL-SF KPS
General health 0.287*
Physical functioning 0.465*
Physical role 0.348*
Emotional role 0.274*
Pain 0.359*
Social function 0.308*
Emotional well-being 0.261*
Energy/fatigue 0.357*
Burden of kidney disease 0.439*
Cognitive function 0.151
Quality of social interaction 0.311*
Symptom/problem list 0.307*
Effects of kidney disease 0.248*
Sexual function 0.289*
Sleep 0.210
Social support 0.163
Work status 0.254*
Patient satisfaction -0.027
Dialysis staff encouragement 0.213
The Karnofsky Performance Scale is described in
Ref. 18.
*P < 0.05 for the correlation.
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do not rule out the possibility of changing
this activity if future studies with renal pa-
tients from other regions of the country show
that they do not understand this item.
Even though the KDQOL-SF has been
translated into various languages, its psy-
chometric properties have been published
only in Japan (26) and in Holland (27).
In our study we observed mean scores for
the dimensions of the Portuguese version of
the KDQOL-SF ranging from 22.3 (Work
status) to 90.8 (Encouragement by dialysis
staff), in agreement with the results of the
Dutch study (27) (range: 21.7 to 82.9, re-
spectively). A higher mean value for the
latter dimension (82.3) was encountered also
in the Japanase study among patients who
received assistance to fill out the question-
naire. However, a survey by Bakewell et al.
(28) using the KDQOL revealed that pa-
tients undergoing dialysis tend to obtain lower
scores on this dimension with a longer treat-
ment time.
The evaluation of intra-observer and in-
ter-observer reliability of the Portuguese ver-
sion of the questionnaire revealed excellent
correlation with all dimensions. The same
results were obtained in the evaluation of the
dimensions by the Cronbach’s α, which
showed correlation coefficients higher than
0.80.
In the evaluation of internal consistency
reliability, the dimension “Quality of social
interaction” obtained lower values in Japan
and Holland (r = 0.35 and r = 0.39, respec-
tively) (26,27). For this reason, these inves-
tigators suggest caution when this dimen-
sion is evaluated since the reliability of the
original US version was higher (0.61). This
problem did not occur in the present study (r
= 0.81 for intra-observer reliability and r =
0.86 for inter-observer reliability).
The clinical validity of the Portuguese
version of the KDQOL-SF was demonstrated
by the significant correlations with the co-
morbidity parameter. The sociodemographic
parameter showed statistically significant
correlations with generic and disease-tar-
geted dimensions. The time of treatment pa-
rameter, however, did not correlate with the
dimensions of the questionnaire. It is pos-
sible to assume that for these clinically stable
patients the time of treatment did not inter-
fere with their regular activities at the time of
evaluation. The co-morbidity parameter
showed the highest negative correlation with
the dimensions, suggesting that this param-
eter indeed compromises the HRQOL.
In general, the components of the Portu-
guese version of the KDQOL-SF correlated
significantly with the components of the NHP
(17). The best correlations occurred between
Emotional well-being and Emotional reac-
tions (r = -0.778); Physical functioning and
Physical capacity (r = -0.715); Quality of
social interaction and Emotional reactions
(r = -0.729), and between Sleep and Sleep
(r = -0.690). These data confirm that the
Table 6. Pearson’s correlation coefficient between the dimensions of the Brazilian
Portuguese version of the Kidney Disease and Quality of Life - Short Form and the
dimensions of the Kidney Disease Questionnaire (KDQ, N = 74).
Dimensions of the Physical Fatigue Depression Relationship Frustration
KDQOL-SF symptom with others
General health 0.218 0.416* 0.439* 0.285* 0.311*
Physical functioning 0.488* 0.577* 0.383* 0.501* 0.314*
Physical role 0.443* 0.504* 0.461* 0.481* 0.319*
Emotional role 0.379* 0.406* 0.447* 0.559* 0.375*
Pain 0.483* 0.467* 0.358* 0.394* 0.312*
Social function 0.330* 0.460* 0.496* 0.593* 0.506*
Emotional well-being 0.400* 0.453* 0.708* 0.672* 0.611*
Energy/fatigue 0.355* 0.679* 0.643* 0.506* 0.457*
Burden of kidney disease 0.361* 0.503* 0.486* 0.607* 0.476*
Cognitive function 0.296* 0.431* 0.558* 0.538* 0.459*
Quality of social interaction 0.284* 0.500* 0.662* 0.623* 0.570*
Symptom/problem list 0.549* 0.624* 0.435* 0.467* 0.365*
Effects of kidney disease 0.430* 0.422* 0.233* 0.378* 0.275*
Sexual function 0.098 0.079 0.098 0.184 -0.059
Sleep 0.364* 0.406* 0.406* 0.465* 0.387*
Social support 0.045 0.282* 0.365* 0.381* 0.230*
Work status 0.132 0.257* 0.246* 0.276* 0.244*
Patient satisfaction 0.028 0.130 -0.044 0.106 0.080
Dialysis staff 0.075 0.222 0.084 0.075 0.142
encouragement
The Brazilian Portuguese version of the Kidney Disease Questionnaire is described in
Refs. 21 and 22.
*P < 0.05 for the correlation.
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items were correspondents and are measur-
ing what they propose to measure. The ab-
sence of significant correlations between
NHP dimensions and the dimension “Patient
satisfaction” can be attributed to the fact that
there are no items in the NHP that measure
patient satisfaction with treatment.
As expected, the best correlation between
the KDQOL-SF and the KPS (18) was ob-
tained with the dimension Physical function-
ing (r = 0.465) because both scales evaluate
physical capacity.
In the comparison between the KDQOL-
SF and the KDQ, most dimensions presented
statistically significant correlations, with the
best correlation being observed between the
Emotional well-being and Depression (r =
0.708), respectively.
Overall, the psychometric properties of
the Portuguese version of the KDQOL-SF
were very good and similar to those obtained
in the US population (7), because the mean
values in both populations positioned be-
tween 60 and 70 and the internal consistency
between the questionnaires (original version
and Portuguese version) for most of dimen-
sions was higher than 0.80.
This study is the third one reporting the
complete process of translation and valida-
tion of the KDQOL-SF (26,27). Since our
results demonstrate high reliability and va-
lidity of this questionnaire for Brazilian pa-
tients with ESRD, we conclude that the Por-
tuguese version of the KDQOL-SF can be
used by health care professionals interested
in assessing patients’ health-related quality
of life for clinical and investigative pur-
poses. We believe that it will be important to
assess the longitudinal validity of the
KDQOL-SF dimensions in future studies by
determining if this questionnaire is able to
reflect clinical changes over time. It will also
be important to determine whether the self-
applied procedure or application of the ques-
tionnaire by an interviewer is best.
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